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a b s t r a c t 
Background: Endocrine-cerebro-osteodysplasia (ECO) syndrome is a genetic disorder associated with con- 
genital defects of the endocrine, cerebral, and skeletal systems in humans. ECO syndrome is caused by 
mutations of the intestinal cell kinase ( ICK ) gene, which encodes a mitogen-activated protein (MAP) 
kinase-related kinase that plays a critical role in controlling the length of primary cilia. Lack of ICK func- 
tion disrupts transduction of sonic hedgehog (SHH) signaling, which is important for development and 
homeostasis in humans and mice. Craniofacial structure abnormalities, such as cleft palate, are one of the 
most common defects observed in ECO syndrome patients, but the role of ICK in palatal development has 
not been studied. 
Methods: Using Ick -mutant mice, we investigated the mechanisms by which ICK function loss causes cleft 
palate and examined pharmacological rescue of the congenital defects. 
Findings: SHH signaling was compromised with abnormally elongated primary cilia in the developing 
palate of Ick -mutant mice. Cell proliferation was signiﬁcantly decreased, resulting in failure of palatal 
outgrowth, although palatal adhesion and fusion occurred normally. We thus attempted to rescue the 
congenital palatal defects of Ick mutants by pharmacological activation of SHH signaling. Treatment of 
Ick -mutant mice with an agonist for Smoothened (SAG) rescued several congenital defects, including cleft 
palate. 
Interpretations: The recovery of congenital defects by pharmacological intervention in the mouse models 
for ECO syndrome highlights prenatal SHH signaling modulation as a potential therapeutic measure to 
overcome congenital defects of ciliopathies. 
© 2019 The Author(s). Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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utations in the intestinal cell kinase ( ICK ) gene in humans. Pre-
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 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) ontrolling the length of primary cilia, which act as control tow-
rs for various signaling pathways essential for animal develop-
ent and homeostasis. Among many signaling pathways that are
ependent on primary cilia, key SHH signaling components are
hown to be mislocalized within the elongated or shortened pri-
ary cilia and proposed to be a major reason for the congenital
efects exhibited in ECO syndrome. Mouse models carrying mu-
ations in the Ick gene recapitulate the spectrum of human ECO
yndrome developmental anomalies, including cleft palate, hydro-
ephalus, polydactyly, and skeletal defects; however, it is not en-
irely clear whether disrupted SHH signaling is the sole reason forunder the CC BY-NC-ND license. 
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f  developmental defects caused by ICK deﬁciency in ECO syndrome
patients and mouse models. 
Added value of this study 
To test whether compromised SHH signaling is the major cause
of congenital anomalies in Ick mutants, we used cleft palate as a
model system because it is one of the most common defects ob-
served in ECO syndrome patients and Ick -mutant mice. We ﬁrst
found that SHH signaling is indeed compromised in the develop-
ing palatal tissues in Ick -mutant mice. The reduced SHH signaling
appeared to cause a decrease in cell proliferation, leading to fail-
ure of palatal-shelf outgrowth. The two palatal shelves remained
separated at either side, resulting in cleft palate. If disrupted SHH
signaling due to abnormal cilia is indeed the key cause of the cleft
palate, re-activation of the compromised SHH signaling in Ick mu-
tants could rescue the cleft palate defect. We tested this hypothesis
by activating SHH signaling in developing mouse embryos using a
small molecule SHH agonist (SAG). We observed that SAG injection
into pregnant mice rescued multiple congenital defects, including
cleft palate, in Ick -mutant embryos, indicating that SHH signaling
is indeed the main effector that is compromised by abnormal cilia
and leads to congenital anomalies in Ick -mutant mice. 
Implications of all the available evidence 
These results provide in vivo evidence that disrupted SHH sig-
naling is the primary cause of abnormal craniofacial development
in ECO syndrome. Furthermore, our demonstration of the rescue of
cleft palate by pharmacological intervention suggests that prena-
tal modulation of developmental signaling using a small chemical
compound may provide a therapeutic option for rescuing congeni-
tal defects in genetic diseases, such as ciliopathies. 
1. Introduction 
Endocrine-cerebro-osteodysplasia (ECO) syndrome
[MIM:612651] is a recessive genetic disorder associated with
multiple congenital defects in the endocrine, cerebral, and skeletal
systems in humans [1] . ECO syndrome is caused by mutations
in the intestinal cell kinase ( ICK ) gene [1–3] . Mouse models
carrying mutations in the Ick gene recapitulate the spectrum of
developmental anomalies, including cleft palate, hydrocephalus,
polydactyly, delayed skeletal development, and abnormal lung
development, observed in human ECO patients [3–5] . ICK has
been shown to play a critical role in the regulation of primary
cilia length. Thus, abnormal ICK function results in abnormally
elongated primary cilia and leads to disrupted sonic hedgehog
(SHH) signal transduction [ 3 , 4 ]. SHH target genes, such as Gli1 and
Ptch1 , are downregulated in the mesenchyme of developing limb
buds, growth plates, and perichondrium in Ick -mutant embryos [ 3 ,
4 ]. These results suggest that abnormal SHH signaling is a major
pathological mechanism underlying the developmental defects
caused by ICK deﬁciency in humans and mice. 
Congenital craniofacial abnormalities, such as cleft palate/lip,
are one of the most common defects observed in ECO syndrome
[1] . Palatal development depends on reciprocal interactions be-
tween palatal ectoderm and underlying mesenchyme, and SHH is
an important epithelial signal that promotes palatal outgrowth [6] ;
however, it has not been directly examined whether abnormal cil-
iary elongation and the resultant reduced SHH signaling are indeed
major causes of cleft palate in ECO syndrome. 
Currently, it is not feasible to correct developmental defects,
such as ECO syndrome or other ciliopathies that are caused by ge-
netic mutations. Several attempts have been made to rescue con-
genital defects using pharmacological interventions that either ac-ivate or inhibit causative signaling pathways affected by the ge-
etic mutations. Aortic aneurysm in Marfan syndrome, a genetic
isorder caused by mutations in the ﬁbrillin 1 ( FBN1 ) gene, can
e rescued by treatment with losartan, an angiotensin II type 1
eceptor blocker [7] . In addition, treatment with rapamycin signif-
cantly alleviates the polycystic kidney phenotype in zebraﬁsh cil-
opathy models, mouse models for polycystic kidney disease (PKD),
nd human autosomal-dominant PKD (ADPKD) patients [ 8 , 9 ]. Fur-
hermore, treatment with dantrolene, an inhibitor of the endoplas-
ic reticulum (ER)-localized ryanodine receptors and a regulator
f ER calcium homeostasis, prevents cell death in neural progeni-
or cells derived from induced pluripotent stem cells (iPSCs) of a
olfram syndrome patient [10] . 
In this study, we analyzed the developing palate of Ick- mutant
mbryos and found that abnormal SHH signaling is a major patho-
ogical mechanism that leads to the cleft palate in the presence of
CK dysfunction. In addition, we sought to rescue the cleft palate
f Ick -mutant mice via pharmacological activation of SHH signal-
ng using a small molecule SHH pathway agonist (SAG). Intrigu-
ngly, we observed that treatment of pregnant mice with SAG res-
ued multiple congenital defects, including cleft palate, in the Ick -
utant embryos. These results provide in vivo evidence that SHH
ignaling is the primary cause of abnormal craniofacial develop-
ental processes in ECO syndrome and further deepen our under-
tanding of the pathogenesis of human genetic ciliopathies, sup-
orting the development of therapeutic measures to alleviate con-
enital abnormalities caused by gene mutations. 
. Materials and Methods 
.1. Mice and SAG treatment 
Mice carrying a knockout ﬁrst allele of the Ick gene ( Ick tm1a/tm1a )
ere previously described [4] . Ick tm1a/ + mice were housed in a
peciﬁc-pathogen-free animal facility with constant temperature
nd humidity and ad libitum access to food and water. The em-
ryos were obtained from time-mated pregnant mice. The day
hat a vaginal plug was conﬁrmed was designated as embryonic
ay (E) 0.5. SAG was injected intraperitoneally into pregnant mice
20 mg/kg), and the embryos were harvested between E12.5 and
18.5 for analysis. All animal protocols were approved by the Insti-
utional Animal Care and Use Committee at Yonsei University Col-
ege of Medicine. 
.2. Histology and in situ hybridization 
For histological analysis and in situ hybridization, embryos were
xed in 4% paraformaldehyde overnight, mounted in OCT com-
ound (Tissue-Tek; Tokyo, Japan), and sectioned at a thickness
f 12 μm onto Superfrost Plus slides (Tissue-Tek; Tokyo, Japan)
sing a cryostat (Thermo Scientiﬁc; Massachusetts, USA). Hema-
oxylin and eosin (H&E) staining as well as section and whole-
ount in situ hybridization were performed as described pre-
iously [ 4 , 11 ]. Antisense RNA probes for Shh, Ptch1 [11] , Gli1
12] , Smo (+20 6 6-+2980, NM_176996.4), and Foxf1 ( + 588- + 1434,
M_010426.2) were labeled with digoxigenin. All histology and in
itu hybridization ﬁgures are representative of at least three differ-
nt samples in two or more independent experiments. 
.3. Scanning electron microscopy 
For scanning electron microscopy, palates of E12.5 Ick tm1a/ + and
ck tm1a/tm1a embryos were isolated and ﬁxed with 2.5% glutaralde-
yde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer
pH 7.4) at 4 °C overnight. The specimens were washed three times
or 30 min in 0.1 M sodium cacodylate buffer (pH 7.4). Then the
J.-O. Shin, J. Song and H.S. Choi et al. / EBioMedicine 49 (2019) 305–317 307 
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t  pecimens were post-ﬁxed with 1% osmium tetroxide at 4 °C for
 h and immersed in saturated thiocarbohydrazide at room tem-
erature for 20 min. Next, the specimens were dehydrated using a
raded ethanol series, dried using a critical point dryer (Leica EM
PD300; Solms, Germany), aﬃxed on a stub, and coated with plat-
num to a thickness of 20–30 nm using a sputter coater (E1030;
itachi, Tokyo Japan). Lastly, the platinum-coated specimens were
ounted on a stub holder and imaged using a Schottky emission
canning electron microscope (JSM 7001F, JEOL, Tokyo, Japan). Five
ifferent specimens were examined for SEM images. 
.4. Cell proliferation and cell death assays 
Cell proliferation and cell death assays were performed as pre-
iously described [11] . For the cell proliferation assay, 5-ethynyl-
 
′ -deoxyuridine (EdU; Invitrogen, Massachusetts, USA) was in-
ected intraperitoneally into a pregnant female mouse at E12.5
t a concentration of 10 mg/g body weight. Embryos were har-
ested and ﬁxed in 4% paraformaldehyde in 1 ×PBS overnight
t 4 °C. Embryos were then mounted and frozen in OCT com-
ound (Tissue-Tek; Tokyo, Japan) and sectioned at a thickness
f 12 μm onto Superfrost Plus slides (Tissue-Tek; Tokyo, Japan)
sing a cryostat (Thermo Scientiﬁc; Massachusetts, USA). EdU-
abeled cells were identiﬁed using the Click-IT EdU imaging Alexa
luor 488 Kit (Invitrogen; Massachusetts, USA). 4 ′ ,6-diamidino-2-
henylindole (DAPI) was used for nuclear staining. For the cell
eath assay, apoptotic cells were detected using the ApopTag Plus
eroxidase In Situ Apoptosis Detection Kit (S7101, Millipore; Mas-
achusetts, USA), which detects apoptotic cells by labeling DNA
trand breaks via the indirect TUNEL method. Three different spec-
mens were examined for cell proliferation and TUNEL assays. 
.5. Quantitative real-time polymerase chain reaction (qPCR) 
Palate tissues from E12.5 Ick tm1a/ + and Ick tm1a/tm1a embryos
ere dissected in cold DEPC-treated PBS, followed by RNA iso-
ation with the Trizol reagent (Thermo Fisher Scientiﬁc, USA)
ccording to the manufacturer’s instructions. cDNA synthesis
as performed using PrimeScript TM 1st strand cDNA Syn-
hesis Kit (TaKaRa, Japan). qPCR was performed using the TB
reen TM Premix Ex Taq TM (TaKaRa, Japan) and an A28132 real-
ime PCR instrument system (Thermo Fisher Scientiﬁc, USA).
he primer sequences of the genes are as follows: Ptch1 , 5 ′ -
GTCTGGAGTCCGGATGG-3 ′ and 5 ′ -TGATTGTGGAAGCCACAGAAAA- 
 
′ ; Gli1 , 5 ′ -GGTGCTGCCTATAGCCAGTGTCCT-3 ′ and 5 ′ -
TGCCAATCCGGTGGAGTCAGACCC-3 ′ ; Smoothened , 5 ′ -
TCGGGCAAGACATCCTATTT-3 ′ and 5 ′ -ACTCACGGAGTCTCCATCTAC- 
 
′ ; GAPDH , 5 ′ -CCTGTTGCTGTAGCCGTATT-3 ′ and 5 ′ -
ACAGCAACTCCCACTCTTC-3 ′ . Student’s t -tests were used to
etermine statistical signiﬁcance. P < 0.05 was considered as
igniﬁcant. 
.6. Palate explant culture and immunohistochemistry for Ki67 
Palate explant culture was performed as previously described
13] . Brieﬂy, tissues containing palatal shelves were dissected
rom E13.5 embryos and placed on ﬁlter Trowell-type organ cul-
ures. Palatal shelves were brought into contact and cultured
n DMEM/F12 (Gibco; Massachusetts, USA) supplemented with
0 μg/ml ascorbic acid (Sigma; Missouri, USA) and 1% peni-
illin/streptomycin without fetal bovine serum at 37 °C in a CO 2 
hamber. The palatal explants were incubated for 48 h to con-
uct in vitro palatal fusion assay ( Fig. 4 ) or for 24 h to examine
hanges in gene expression or cell proliferation ( Fig. 7 ). The cul-
ure medium containing 200 nM SAG or DMSO was replaced every4 h. The cultured palate tissues were ﬁxed in 4% paraformalde-
yde, embedded in OCT compound, and sectioned at a thickness
f 12 μm onto Superfrost Plus slides (Tissue-Tek; Tokyo, Japan).
ections were incubated with Ki67 antibody (Thermo Scientiﬁc;
assachusetts, USA) at 4 °C overnight. After washing with PBST,
he specimens were sequentially incubated with secondary anti-
ody and streptavidin peroxidase. The Ki67-positive cells were vi-
ualized using a diaminobenzidine reagent kit (Invitrogen; Mas-
achusetts, USA) and the sections were counterstained with hema-
oxylin. Palate explant culture experiments were performed using
our specimens in each analysis, which were repeated three times. 
.7. Quantitation, measurement, and statistical analysis 
EdU-positive cells were counted in the epithelium and mes-
nchyme of palatal shelves of control and mutant embryos. The
enotypes were blinded to the investigators conducting the cell
ounting. Cell proliferation rate was calculated as a percentage of
dU-positive cells per DAPI-positive cells. Lengths of primary cilia
ere measured from SEM images of E12.5 embryos, and distances
etween right and left palatal shelves were measured from im-
ges of E18.5 embryos using the ImageJ software. All cell counting
nd length measurement were conducted in at least three different
mbryos for each genotype. Two-tailed, unpaired Student’s t -tests
ere used to determine statistical signiﬁcance. P < 0.05 was con-
idered as signiﬁcant. Data are shown as means ± s.d. 
. Results 
.1. ICK deﬁciency caused cleft palate and abnormally elongated 
rimary cilia in the developing palate of mice 
To investigate the role of ICK in palate development, we an-
lyzed the palates of Ick tm1a/tm1a embryos at E18.5 ( Fig. 1 ). Gross
orphological analysis revealed a completely divided palate along
he anteroposterior axis including the entire primary and sec-
ndary palates in Ick tm1a/tm1a mice compared to the correctly
ormed palate in Ick tm1a/ + control mice ( Fig. 1 A and E). Histolog-
cally, the palatal shelves from the left and right sides were fused
t the midline along the anteroposterior axis in Ick tm1a/ + heterozy-
ous control mice ( Fig. 1 B–D). In contrast, the palatal shelves of
ck tm1a/tm1a mice remained separated, resulting in a complete cleft
alate ( Fig. 1 F–H). The palatal shelves were elevated to a horizon-
al position in the anterior region ( Fig. 1 F) but not in the mid-
le and posterior regions in Ick tm1a/tm1a mice ( Fig. 1 G–H). The cleft
alate phenotype was completely penetrant in Ick tm1a/tm1a mutant
mbryos ( n = 10/10). 
We further analyzed the developing palates at E12.5 before
alatal fusion by scanning electron microscopy ( Fig. 1 I–P). The dis-
ance between the anterior palatal shelves in the Ick tm1a/tm1a mu-
ants was wider than that in Ick tm1a/ + control embryos ( Fig. 1 I, M,
ed arrows). Moreover, the formation of palatal rugae was evident
n the palatal shelves of Ick tm1a/ + control embryos; however, this
tructure was not present in Ick tm1a/tm1a mutants ( Fig. 1 I, J, M, N).
he distance of the medial maxillary prominence that later devel-
ps into the lip was longer in Ick tm1a/tm1a embryos than in Ick tm1a/ + 
mbryos ( Fig. 1 K, O; black arrows). In addition, the surface of the
rimary palatal shelves that were derived from the medial nasal
rominence were rugged in Ick tm1a/tm1a mutants ( Fig. 1 I, K, L, M, O,
). 
It has previously been reported that ICK plays a critical role in
he regulation of primary cilia length during limb and lung devel-
pment [ 4 , 5 ]. Consistent with previous reports, the lengths of pri-
ary cilia in the palatal shelves were signiﬁcantly elongated and
he morphology of the ciliary tip region bulged in Ick tm1a/tm1a mu-
ant embryos compared with Ick tm1a/ + control embryos ( Fig. 1 J ′ , L ′ ,
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Fig. 1. Defects of palates and primary cilia in Ick -deﬁcient mice. (A) An Ick tm1a/ + embryo showing an intact palate at E18.5. (B–D) Hematoxylin and Eosin staining showing 
normal palate from the anterior to the posterior regions in Ick tm1a/ + embryo. (E) An Ick tm1a/tm1a embryo showing a cleft palate at E18.5. (F-H) Hematoxylin and Eosin stain- 
ing showing separation of palatal shelves on either side in Ick tm1a/tm1a embryo at E18.5. (I-P) Scanning electron microscopy analysis of developing palates in Ick tm1a/ + and 
Ick tm1a/tm1a embryos at E12.5. (I, M) Overall view of the developing palates at E12.5. (J, N) High magniﬁcation of palatal rugae in the anterior region of the developing palate 
in Ick tm1a/ + and Ick tm1a/tm1a mice. (K, O) Morphology of primary palate and upper lip in Ick tm1a/ + and Ick tm1a/tm1a mice. (L, P) Primary cilia of the palatal epithelium in Ick tm1a/ + 
and Ick tm1a/tm1a mice. (Q) Lengths of primary cilia in the developing palates of Ick tm1a/tm1a embryos were signiﬁcantly elongated compared with those of Ick tm1a/ + embryos. 
Data are shown as mean ± s.d. ∗∗p < 0.01. PP, primary palate; PS, palatal shelf; NC, nasal cavity; and R, rugae. Green dotted line, primary palate; red two-way arrows, 
distance between left and right palatal shelves; red dotted line, secondary palate; blue dotted box, primary cilia; red arrow, bulged tip of primary cilia; yellow dotted line, 
palatal rugae; and black dotted line, section plane. Scale bars, A, E: 1 mm; B-D, F-H, I, K, M, O: 100 μm; J, L, N, P: 20 μm; J ′ , L ′ , N ′ , P ′ : 20 nm. 
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r  N ′ , P ′ , Q). These results suggest that ICK plays an essential role in
the regulation of the length of primary cilia for normal palatal de-
velopment. 
3.2. ICK deﬁciency resulted in disrupted SHH signaling in the 
developing palate of mice 
The observed, abnormally elongated primary cilia prompted us
to examine SHH signaling activity in the developing palate becauserimary cilia act as essential signaling centers for SHH signal trans-
uction, which is crucial for animal development and homeosta-
is [14] . In the developing palate, Shh is expressed in the ridges
f developing palatal rugae and positively regulates expression of
atched 1 ( Ptch1 ), GLI-Kruppel family member GLI1 ( Gli1 ), and
orkhead box F1 ( Foxf1 ) [ 6 , 15 ]. We examined these genes using
hole-mount and section in situ hybridization in E12.5 develop-
ng palates of mouse embryos ( Fig. 2 ). Consistent with previous
eports, two ridges of developing rugae expressed Shh and its tar-
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Fig. 2. Gene expression analyses in the developing palate in Ick -deﬁcient mice. (A–F) Whole mount in situ hybridization results showing expression of Shh (A, D), Ptch1 (B, 
E), and Gli1 (C, F) in Ick tm1a/ + and Ick tm1a/tm1a embryos at E12.5. (G–L) Section in situ hybridization results showing expression of Foxf1 (G, J), Ptch1 (H, K), and Gli1 (I, L) in 
the palatal mesenchyme and epithelium in Ick tm1a/ + and Ick tm1a/tm1a embryos. Ic, incisor; R, palatal rugae; PP, primary palate; PS, palatal shelf; SP, soft palate; OC, oral cavity. 
black dotted line, section plane. Scale bars, A–F: 50 0 μm; G–L: 20 0 μm. 
g  
e  
e  
s  
c  
e  
f  
(  
c  
G  
l  
(  
o  
g  
s  
iet genes Ptch1 and Gli1 in each palatal shelf of Ick tm1a/ + control
mbryos ( Fig. 2 A–C and Fig. S1). In Ick tm1a/tm1a mutant embryos,
xpression levels of Shh were generally unaffected but its expres-
ion domains were slightly expanded in less clearly deﬁned rugae
ompared with those of Ick tm1a/ + embryos ( Fig. 2 D). Interestingly,
xpression of Ptch1 and Gli1 was greatly reduced and appeared dif-
use without a distinct palatal rugae pattern in Ick tm1a/tm1a embryos
 Fig. 2 E and F and Fig. S1). In situ hybridization of tissue sectionsonﬁrmed these ﬁndings, showing that expression of Ptch1 and
li1 was downregulated in the palatal mesenchyme and epithe-
ium in Ick tm1a/tm1a embryos at E12.5 compared to control embryos
 Fig. 2 H, I, K, L). Foxf1 was also downregulated in the mesenchyme
f the developing palatal shelf ( Fig. 2 G and J). These results sug-
est that ICK is essential for the regulation of ciliary length and
ubsequent normal transduction of SHH signaling in the develop-
ng palate. 
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I  3.3. Cleft palate in Ick -deﬁcient mice was caused by impaired palatal 
growth that resulted from decreased cell proliferation 
It has been shown that SHH signaling contributes to palatal
outgrowth by promoting cell proliferation [6] . Therefore, we deter-
mined whether the cleft palate in Ick tm1a/tm1a mutants results from
insuﬃcient extension of palatal shelves toward the midline due
to decreased cell proliferation. Cell proliferation was analyzed by
counting the number of cells in the developing palate that had in-
corporated EdU at E12.5. The Ick tm1a/tm1a embryos exhibited a sig-
niﬁcant reduction of cell proliferation in the palatal mesenchyme
compared with Ick tm1a/ + control embryos ( Fig. 3 A, A-a, B, B-a, E).
Interestingly, the number of EdU-positive cells was signiﬁcantly
decreased in the palatal epithelium on the oral side ( Fig. 3 A-b,
B-b, E) but not in the nasal side epithelium ( Fig. 3 A-c, B-c, E).
Since the oral side but not nasal side epithelium expresses Ptch1
in Ick tm1a/ + embryos and this Ptch1 expression was dramatically
reduced in Ick tm1a/tm1a embryos ( Fig. 2 H, K), the decrease of EdU-
positive cells in the palatal epithelium appears to be closely related
with reduced SHH activity. In contrast, TUNEL-positive apoptotic
cells were not detected in the palatal mesenchyme or epithelium
in either Ick tm1a/ + or Ick tm1a/tm1a embryos ( Fig. 3 C and D). These re-
sults suggest that Ick deﬁciency causes decreased cell proliferation
in Ptch1 -positive regions in the developing palate. 
The defective fusion between bilateral palatal shelves is one of
the main causes of cleft palate [16] . Primary cilia have also been
implicated in mediating signaling pathways important for palatal
fusion including Wnt and transforming growth factor beta (TGF β)
signaling [ 14 , 17 ]. To test whether the cleft palate in Ick tm1a/tm1a 
embryos is also attributed to disruption of other signaling path-
ways important for palatal fusion, we performed ex vivo palatal fu-
sion analysis. Palatal fusion involves the formation of the midline
epithelial seam (MES) and its subsequent degeneration, leading to
palatal mesenchymal conﬂuence [16] . A pair of palatal shelves dis-
sected from E13.5 embryos were placed facing one another in an
explant culture system ( Fig. 4 A–C). After 48 h in culture, we ob-
served complete fusion between the palatal shelves, assessed by
the complete degeneration of MES, in both Ick tm1a/ + and Ick tm1a/tm1a 
embryos ( Fig. 4 D–E; dotted rectangles). Together, these results sug-
gest that the cleft palate in Ick tm1a/tm1a animals is caused by defec-
tive palatal outgrowth resulting from decreased cell proliferation
and not by defective fusion of the MES. 
3.4. Timely activation of SHH signaling by SAG rescued the 
developmental defects in Ick tm1a/tm1a mutant embryos 
Our analyses indicated that the lack of ICK function in the de-
veloping palate causes defective cilia and a reduction of SHH sig-
naling, leading to a decrease of cell proliferation, a subsequent
failure of palatal outgrowth, and ultimately a cleft palate. Thus,
we hypothesized that activation of SHH signaling during the crit-
ical developmental period for palate outgrowth could rescue the
cleft palate in Ick tm1a/tm1a embryos. We tested this idea by treating
Ick tm1a/tm1a embryos with a synthetic agonist of the SHH pathway,
SAG [18] . SAG is able to cross the gut, placenta, and blood-brain
barrier [19–21] and constitutively activate SHH signaling by di-
rectly binding to the SHH signaling transducer Smoothened (Smo)
[ 19 , 22 ]. 
Palatal primordia emerge from the maxillary prominence and
rapidly grow bilaterally around E11.0 and E11.5 [23] . Thus, we
injected DMSO or SAG intraperitoneally into pregnant mice at
E10.5, E11.25, or E13.5 and analyzed the treated embryos at E18.5
( Fig. 5 A). Interestingly, we observed rescue of cleft palate in
Ick tm1a/tm1a embryos that were treated with SAG at E10.5 and
E11.25 but not at E13.5, and treatment at E11.25 resulted in the
best rescue eﬃciency ( Fig. 5 F). Embryos treated with SAG at E10.5uffered from other developmental defects, such as polydactyly,
educed head size, cleft lip, edema, and spina biﬁda ( Fig. 5 B–
), consistent with previous reports that administration of SAG
n early gestation causes preaxial polydactyly in mice [24] . Em-
ryos treated with SAG at E11.25 showed generally better overall
orphology with a complete fusion of the palate when rescued
 Fig. 5 E, O). These results suggest that the outcome of SAG treat-
ent during the prenatal stage is dependent on the developmen-
al stage of treatment administration. Histological analysis showed
hat the secondary palate was well fused from anterior to posterior
nd that the nasal cavity and oral cavity were well separated in
ck tm1a/tm1a embryos treated with SAG but not with DMSO at E11.25
 Fig. 5 G–R). Together, these results suggest that timely administra-
ion of SAG can rescue the cleft palate in lck -mutant mice, and this
iming is correlated with the developmental timing of innate Shh
ignaling. 
Our results showed that the extent of phenotypic recovery by
AG treatment in E11.25 Ick tm1a/tm1a embryos was variable ( Fig. 5 F).
he rescue phenotypes could be divided into three categories:
ompletely rescued (6/16, 37.5%), partially rescued (3/16, 18.75%),
nd not rescued (7/16, 43.75%; Fig. S2). The palates of partially res-
ued embryos were fused, but the palatal rugae patterning was ir-
egular compared with those of completely rescued embryos (Fig.
2B–C). In contrast, the palates of the embryos that were not res-
ued were not fused, displaying a complete cleft palate (Fig. S2D).
omparing the SAG-treated mutants that were not rescued with
MSO-treated mutants, we noticed that the distance of the ante-
ior palatal shelves of SAG-treated mutants was slightly, yet sig-
iﬁcantly, closer compared with those of DMSO-treated mutant
mbryos (Fig. S3G). In addition, the palates of the SAG-treated
utants exhibited more regular rugae patterning compared with
hose of DMSO-treated mutant embryos (Fig. S3A–F; 4/7, 57.1%). 
An inactivation mutation in the human ICK gene shows multi-
le visceral abnormalities, including a hypoplastic ileum [3] . Our
ck- mutant mouse model also displayed defects in gastrointestinal
evelopment with short underdeveloped small and large intestines
Fig. S4E–F) and imperforate rectum (Fig. S4G). Since SAG was sys-
emically applied in our experimental design, we examined the ef-
ect of SAG on the intestinal defects in the Ick tm1a/tm1a embryos.
nterestingly, the intestines of SAG-treated mutant embryos were
longated compared with those of DMSO-treated embryos (Fig. S4;
/11, 18.18%). Rescue of the imperforate rectum was also observed
n SAG-treated Ick tm1a/tm1a embryos (Fig. S4; 2/11, 18.18%). 
.5. SAG treatment resulted in increased SHH signaling and cell 
roliferation in the developing palate of Ick tm1a/tm1a embryos 
The restoration of the cleft palate by SAG treatment in
ck tm1a/tm1a embryos prompted us to examine whether SAG indeed
ctivates SHH signaling in the developing palate of Ick tm1a/tm1a mu-
ants. We treated Ick tm1a/ + and Ick tm1a/tm1a pregnant female mice
ith DMSO or SAG at E11.5 and examined expression patterns of
HH target genes such as Ptch1 and Gli1 by in situ hybridization
nd quantitative real-time PCR (qPCR). In situ hybridization results
howed that Ptch1 and Gli1 expression was greatly increased in
AG-treated embryos compared to DMSO-treated embryos in both
ck tm1a/ + and Ick tm1a/tm1a mice ( Fig. 6 A–H). In contrast, Smo expres-
ion was similar between SAG- and DMSO-treated embryos in both
enotypes ( Fig. 6 I–L). qPCR results also showed that mRNA lev-
ls of Ptch1 and Gli1 , but not Smo , were signiﬁcantly increased
n SAG-treated embryos compared to DMSO-treated embryos in
oth Ick tm1a/ + and Ick tm1a/tm1a mice ( Fig. 6 M–O). Interestingly, ex-
ression levels of Ptch1 and Gli1 of SAG-treated Ick tm1a/tm1a em-
ryos were not signiﬁcantly different from those of DMSO-treated
ck tm1a/ + embryos ( Fig. 6 M and N), suggesting that SAG treatment
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Fig. 3. Analyses of cell proliferation and cell death in the developing palates of Ick -deﬁcient embryos at E12.5. (A, B) EdU-positive cells in the developing palates of Ick tm1a/ + 
and Ick tm1a/ + embryos. Higher magniﬁcation images of EdU assay for palatal shelves (A-a and B-a), oral side palatal epithelium (A-b and B-b), and nasal side palatal epithelium 
(A-c and B-c). (C, D) TUNEL-positive cells in the developing palates of the Ick tm1a/ + and Ick tm1a/tm1a embryos. (E) Percentages of EdU-positive cells in the deﬁned regions of 
the palatal shelves of Ick tm1a/ + and Ick tm1a/ + embryos. PS, palatal shelf; white dotted line, counted total cells and EdU-positive cells in the palatal mesenchyme; red dotted 
line, the palatal epithelium on the oral side; and yellow dotted line, the palatal epithelium on the nasal side. Error bars indicate standard deviation. Data are shown as 
mean ± s.d. ∗p < 0.05, ∗∗p < 0.01. n.s., not signiﬁcant. Scale bars, A-D: 200 μm; A-a to B-c: 20 μm. 
312 J.-O. Shin, J. Song and H.S. Choi et al. / EBioMedicine 49 (2019) 305–317 
Fig. 4. In vitro palatal fusion assay in Ick -deﬁcient embryos. (A) Diagrams showing the in vitro organ culture system for analysis of the paired secondary palatal shelves. (B, 
C) Oral-side view of contacted palatal shelves from the Ick tm1a/ + and Ick tm1a/tm1a embryos. (D, E) H&E staining of contacted palatal shelves from the Ick tm1a/ + and Ick tm1a/tm1a 
embryos after 48h in organ culture. Scale bars, D, E: 50 μm. 
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els to control embryos. 
We further examined SAG effects on SHH signaling and cell pro-
liferation using palatal organ culture ( Fig. 7 ). We administered SAG
to the culture medium of the palate organ culture for 24 h. Histo-
logical analysis showed that unlike 48 h cultured palate explants
( Fig. 4 ), the palatal fusion was still undergoing and the MES re-
mained in both Ick tm1a/ + and Ick tm1a/tm1a embryos ( Fig. 6 A, E, black
dotted circles). In situ hybridization analysis showed that the ex-
pression levels of Ptch1 and Gli1 were upregulated in response
to SAG treatment in the palates of Ick tm1a/tm1a mutant embryos
compared to those of DMSO-treated Ick tm1a/ + embryos ( Fig. 7 B, C,
F, G). In addition, SAG treatment increased the number of Ki67-
positive cells in the developing palate of Ick tm1a/tm1a mutant em-
bryos ( Fig. 7 D and H). These results suggest that the Smo agonist
activates SHH signaling in ciliary mutants and promotes cell pro-
liferation in palate organ culture. 
4. Discussion 
In this study, we studied the mechanism by which ICK de-
ﬁciency causes developmental defects in an Ick -mutant mouseodel with focus on the cleft palate phenotype, which is one of
he main clinical features of ECO syndrome. We found that de-
reased SHH signaling caused by abnormal regulation of ciliary
ength is a major cause of cleft palate in Ick -mutant mice ( Fig. 8 ).
n addition, we demonstrated that proper temporal modulation of
HH signaling with a Smo agonist rescues the cleft palate in Ick
utants by activating SHH signaling, which restores palatal cell
roliferation and palatal-shelf outgrowth ( Fig. 8 ). These results sug-
est that timely modulation of key developmental signaling path-
ays using small chemical compounds offers therapeutic poten-
ial to prevent congenital defects in genetic diseases, such as cil-
opathies. 
Mammalian palatogenesis is a multi-step process in which nasal
nd maxillary prominences expand to develop into the primary
nd secondary palatal shelves, respectively, which then fuse to-
ether to form a roof structure that separates the oral and nasal
avities [16] . Outgrowth of the lateral palatal shelves toward the
edial direction is a critical step for an intact palate. Palatal-shelf
utgrowth has been associated with several signaling pathways,
ncluding SHH, ﬁbroblast growth factors (FGFs), and bone mor-
hogenic proteins (BMPs). Crosstalk between SHH signaling in the
arly palatal epithelium and FGF and BMP signaling in the under-
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Fig. 5. Restoration of cleft palate in the Ick- deﬁcient embryos after SAG treatment. (A) Experimental design for the controlled delivery of SAG during palatogenesis. Blue 
arrows indicate injection day and vertical black arrow indicate tissue harvest day. (B-D) Ick tm1a/tm1a mice treated with SAG at E10.5 exhibit hypoplastic forebrain, polydactyly, 
and overgrown skin (B), cleft lip (C), and unclosed neural tube (D) at E18.5. (E) Morphology of E18.5 Ick tm1a/tm1a mice treated with SAG at E11.25. (F) Rescue rate of cleft palate 
in the Ick tm1a/tm1a mice at E18.5 according to time of SAG treatment. (G, K, O) Oral-side view of the palate in the Ick tm1a/ + and DMSO- or SAG-treated Ick tm1a/tm1a embryos 
at E18.5. (H-J, L-N, P-R) Histological analysis of the palatal shelves from the anterior to posterior region of E18.5 Ick tm1a/ + and Ick tm1a/tm1a mice treated with DMSO or SAG 
at E11.25. PP, primary palate; PS, palatal shelf; SP, soft palate; NC, nasal cavity; NS, nasal septum, green dotted line, primary palate; red dotted line, secondary palate. Scale 
bars, G, K: 1 mm; H–J, L–N: 100 μm. 
l  
o  
c
 
E  
r  
v  
f  
s  
b  
o  
[  
t  
i  
(  
m  
c
 
o  
t  
p  
u  
r  
s  
(  
p  
s  
s  
b
 
m  
a  
d  
c  
p  
a  
c  
f  
d  
t  
b  
d  
S  
S  
p
 
s  
f  
p  
p  
p  
T  
e  
p  
p  
i  
e  
i  
t  
r  
f
e  
S  ying mesenchyme drives palatal cell proliferation and palatal-shelf
utgrowth [ 6 , 25 ]. Perturbation of any of these signaling pathways
an disrupt palatal growth and fusion, resulting in cleft palate. 
Although cleft palate is one of the main features observed in
CO syndrome patients, its molecular etiology has not been di-
ectly examined [ 1 , 2 ]. Our results demonstrate that the initial de-
elopment of bilateral palatal shelves is normal in mouse models
or ECO syndrome, yet the palatal shelves fail to grow and remain
eparated on both sides ( Fig. 1 ). This phenotype closely resem-
les that of Shh -deﬁcient mice, which exhibit initial development
f palatal shelves and then defective palatal outgrowth and fusion
 6 , 15 ]. Consistent with these results, downstream SHH signaling
argets, such as Ptch1, Gli1 , and Foxf1, were greatly downregulated
n the palatal epithelium and mesenchyme of Ick -deﬁcient mice
 Fig. 2 ). These results suggest that abnormal SHH signaling is a
ajor pathological mechanism that underlies development of the
left palate in ECO syndrome. 
During palatogenesis, palatal shelves extensively proliferate to
utgrow ventrally and then horizontally, and ultimately generate
he fusion [16] . At the elongation stage, SHH promotes palatal cell
roliferation through activation and maintenance of cell cycle reg-
lators, such as cyclin D1 and cyclin D2 [6] . Consistent with these
esults, Ick tm1a/tm1a embryos, which have disrupted SHH signaling,
howed signiﬁcantly decreased cell proliferation in the palatal cells
 Fig. 3 ). Interestingly, cell proliferation was impaired in the Ptch1 -
ositive palatal mesenchyme and the palatal epithelium on the oral
ide but not in the Ptch1 -negative palatal epithelium on the nasal
ide, indicating that impaired cell proliferation in Ick -deﬁcient em-
ryos is closely associated with SHH signaling. 
Primary cilia in the presumptive palatal shelves of Ick -deﬁcient
ice were abnormally elongated, as shown in the developing limbs
nd lungs of the mutant mice ( Fig. 1 ) [ 3 , 4 ]. Previous studiesemonstrated that ICK negatively regulates ciliary elongation by
ontrolling axonemal microtubule stability or intraﬂagellar trans-
ort (IFT) velocity [26–29] . Thus, cleft palate in ECO syndrome is
ttributable to diminished SHH response in Ptch1 -positive palatal
ells due to the abnormally elongated primary cilia, which stems
rom increased cilia IFT kinetics or axonemal microtubule stability
ue to the lack of ICK function. Consistent with these results, in-
raﬂagellar transport 88 ( IFT88 ), which is essential for the assem-
ly and function of primary cilia, has been proposed to be a can-
idate gene for cleft palate in humans [30] . Since ciliogenesis and
HH signaling is disrupted in Ift88 mutant embryos [30] , abnormal
HH signaling appears to be a common mechanism leading to cleft
alate in ciliopathies. 
Besides SHH signaling, epithelial WNT signaling has been
hown to regulate palatal fusion by regulating transforming growth
actor beta (TGF β) signaling [17] . Although primary cilia are pro-
osed to mediate multiple signaling including WNT [14] , our
alatal fusion assay showed that the mechanisms controlling
alatal fusion are intact in Ick tm1a/tm1a -mutant embryos ( Fig. 4 ).
hese results conﬁrm the notions that SHH signaling is the main
ffector of ciliary function in palate development and that im-
aired SHH signaling is the major mechanism underlying cleft
alate caused by the lack of ICK function. Although SHH signal-
ng is known to be required for craniofacial development during
arly stages around E8 in mice [31] , the development of max-
llary prominence was relatively normal in the Ick -deﬁcient mu-
ants ( Fig. 1 ), suggesting that mediation of SHH signaling by ICK-
egulated ciliogenesis is required for normal palatogenesis after the
ormation of the maxillary prominence. 
Consistent with these ideas, palatal defects in the Ick tm1a/tm1a 
mbryos can be rescued through time-controlled delivery of the
moothened agonist SAG ( Fig. 5 ). Previously, in a mouse model
314 J.-O. Shin, J. Song and H.S. Choi et al. / EBioMedicine 49 (2019) 305–317 
Fig. 6. Expression patterns of SHH target genes in SAG-treated Ick -deﬁcient embryos. (A-L) Section in situ hybridization results showing expression patterns of Ptch1 (A-D), 
Gli1 (E-H), and Smo (I-L) in the palatal shelves of E12.5 Ick tm1a/ + and Ick tm1a/tm1a treated with DMSO or SAG. (M-O) Quantitative real-time PCR results showing expression 
levels of Ptch1 (M), Gli1 (N), and Smo (O) in the palatal shelves of E12.5 Ick tm1a/ + and Ick tm1a/tm1a treated with DMSO or SAG. PS, palatal shelf; OC, oral cavity. Scale bars, A-L: 
200 μm. Data are shown as mean ± s.d. ∗P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001, n.s., not signiﬁcant 
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f  of Down syndrome (DS), SAG treatment was found to restore the
morphology and function of the cerebellum as well as the function
of the hippocampus [32] . Speciﬁcally, a single SAG treatment at
birth in DS mice reversed the defects in cerebellar and hippocam-
pus development and also improved behavior, learning, and mem-
ory. Similar with these ﬁndings, we observed that acute SAG treat-
ment at a speciﬁc prenatal stage can overcome congenital palatal
defects in ECO syndrome, raising the possibility of therapeutic po-
tential for pharmacological intervention in congenital defects of ge-
netic diseases. Rescue of the cleft palate phenotype by SAG treatment conﬁrms
hat abnormal SHH signaling is a primary mechanism underlying
he palatal cleft in Ick -deﬁcient mice; however, we observed con-
iderable variability of the rescued phenotypes, depending on the
iming of treatment. Furthermore, even SAG treatment at E11.25,
hich yielded the best rescue eﬃciency, restored the palatal fu-
ion in only 56% (9/16) of the treated mutant embryos ( Fig. 5 ). This
ariance may be due to ICK roles other than ciliary length regu-
ation, and thus, SHH signaling may not be the sole pathway af-
ected by ICK deﬁciency. Indeed, ICK has been shown to regulate
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Fig. 7. Restoration of SHH signaling and cell proliferation in the SAG-treated Ick -deﬁcient palate. (A, E) H&E staining showing the morphology of control Ick tm1a/ + and 
SAG-treated Ick tm1a/tm1a palates after 24 h in organ culture. (B, C, F, G) Expression patterns of Ptch1 and Gli1 in the developing palates after 24 h in organ culture. (D, H) 
Ki67-positive cells in the developing palates after 24 h in organ culture. Black dotted circles, remaining midline epithelial seam; black dotted line, the margin of the palatal 
epithelium. Scale bars, A–H: 50 μm. 
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Fig. 8. Schematic diagram showing the effects of SAG treatment on cleft palate in the Ick tm1a/tm1a mice. (A) Effects of SAG treatment in the developing palates of Ick tm1a/tm1a 
embryos. (B, C) Schematic views showing the restoration of cleft palate in SAG-treated Ick tm1a/tm1a embryos. PP, primary palate; PS, palatal shelf; OC, oral cavity; NC, nasal 
cavity; and NS, nasal septum 
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m  cell proliferation by modulating the activity of the mammalian tar-
get of rapamycin (mTOR) complex 1 via phosphorylation of Rap-
tor [33] . Thus, cell proliferation in the developing palate may be
regulated by ICK function in cell cycle regulation in addition to
cilia-mediated SHH signaling. However, our cell proliferation assay
showed that activation of SHH signaling by SAG treatment is suf-
ﬁcient to promote cell proliferation in Ick tm1a/tm1a embryos ( Fig. 7 ).
Nevertheless, we cannot entirely exclude the possibility that other
signaling pathways may also be affected by ICK deﬁciency and may
contribute to the cleft palate phenotype as well. It will be interest-
ing to examine if manipulating other signaling pathways in combi-
nation with SAG would increase the rescuing eﬃciency. 
It was shown that Ick is expressed in the small and large in-
testines [34] , and SHH directly regulates patterning and differ-
entiation of the gastrointestinal tract [ 35 , 36 ]. Consistent with
these reports, Ick -deﬁcient mutants also exhibited reduced stom-
ach size, shortened intestines, and imperforate rectum (Fig. S4).
We observed that SAG treatment at E11.25 restores the lengths
of the small and large intestines and the imperforate rectum,
but the reduced size of the stomach is not restored (Fig. S4).
This discrepancy may be because developmental timing that re-
quires SHH signaling is different in different tissues. Thus, it
is crucial to determine the correct timing of pharmacological
intervention to regulate the developmental signaling pathways
according to the understanding of the precise developmental
processes. 
C  Taken together, this study suggests that pharmacologic inter-
ention with a small chemical reagent offers a way to modulate
evelopmental signaling pathways, enabling us to easily dissect the
ausative signaling pathway and reveal the mechanisms underlying
he pathogenesis of genetic disorders. Moreover, further studies on
ther ciliopathies using signaling pathway-modulating agents will
elp us to better understand the fundamental mechanisms of the
ilia-involved organogenesis and to increase the possibility of ther-
py for ciliopathies. 
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